Physiological Consequences of Aging

  • Bindu Kanapuru
  • William B. Ershler

Life expectancy has increased considerably over the past several decades, and this most certainly relates to public health measures, sanitation, advances in medical treatment, and lately, disease prevention strategies. Measured within an individual, one finds evidence for aging in almost all physiological systems.


Herpes Zoster Lower Muscle Mass Sarcopenic Obesity Total Bone Mineral Density Follicular Stimulate Hormone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Lipsitz LA. Dynamics of stability: The physiologic basis of functional health and frailty. J Gerontol 2002;57(3):B115–25.Google Scholar
  2. 2.
    Jones PP, Shapiro LF, Keisling GA, et al. Altered autonomic support of arterial blood pressure with age in healthy men. Circulation 2001;104(20):2424–9.PubMedCrossRefGoogle Scholar
  3. 3.
    Umetani K, Singer DH, McCraty R, Atkinson M. Twenty-four hour time domain heart rate variability and heart rate: Relations to age and gender over nine decades. J Am Coll Cardiol 1998;31(3):593–601.PubMedCrossRefGoogle Scholar
  4. 4.
    Pfeifer MA, Weinberg CR, Cook D, Best JD, Reenan A, Halter JB. Differential changes of autonomic nervous system function with age in man. Am J Med 1983;75(2):249–58.PubMedCrossRefGoogle Scholar
  5. 5.
    Vaitkevicius PV, Fleg JL, Engel JH, et al. Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circulation 1993;88(4 Pt 1):1456–62.PubMedGoogle Scholar
  6. 6.
    O'Rourke MF, Nichols WW. Aortic diameter, aortic stiffness, and wave reflection increase with age and isolated systolic hypertension. Hypertension 2005;45(4):652–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Mantero A, Gentile F, Gualtierotti C, et al. Left ventricular diastolic parameters in 288 normal subjects from 20 to 80 years old. Eur Heart J 1995;16(1):94–105.PubMedCrossRefGoogle Scholar
  8. 8.
    Spirito P, Maron BJ. Influence of aging on Doppler echocardiographic indices of left ventricular diastolic function. Br Heart J 1988;59(6):672–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985;33(4):278–85.PubMedGoogle Scholar
  10. 10.
    Fehrman-Ekholm I, Skeppholm L. Renal function in the elderly (>70 years old) measured by means of iohexol clearance, serum creatinine, serum urea and estimated clearance. Scand J Urol Nephrol 2004;38(1):73–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Rowe JW, Andres R, Tobin JD, Norris AH, Shock NW. The effect of age on creatinine clearance in men: A cross-sectional and longitudinal study. J Gerontol 1976;31(2):155–63.PubMedGoogle Scholar
  12. 12.
    Danziger RS, Tobin JD, Becker LC, Lakatta EE, Fleg JL. The age-associated decline in glomerular filtration in healthy normotensive volunteers. Lack of relationship to cardiovascular performance. J Am Geriatr Soc 1990;38(10):1127–32.PubMedGoogle Scholar
  13. 13.
    Esposito C, Plati A, Mazzullo T, et al. Renal function and functional reserve in healthy elderly individuals. J Nephrol 2007;20(5):617–25.PubMedGoogle Scholar
  14. 14.
    Fuiano G, Sund S, Mazza G, et al. Renal hemodynamic response to maximal vasodilating stimulus in healthy older subjects. Kidney Int 2001;59(3):1052–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Kaplan C, Pasternack B, Shah H, Gallo G. Age-related incidence of sclerotic glomeruli in human kidneys. Am J Pathol 1975;80(2):227–34.PubMedGoogle Scholar
  16. 16.
    Bauer JH. Age-related changes in the renin-aldosterone system. Physiological effects and clinical implications. Drugs Aging 1993;3(3):238–45.PubMedCrossRefGoogle Scholar
  17. 17.
    Garcia Zozaya JL, Padilla Viloria M, Rodriguez L, Castro A. The renin-angiotensin-aldosterone system in normal elderly subjects. Res Commun Chem Pathol Pharmacol 1983;40(2):289–99.PubMedGoogle Scholar
  18. 18.
    Bengele HH, Mathias RS, Perkins JH, Alexander EA. Urinary concentrating defect in the aged rat. Am J Physiol 1981;240(2):F147–50.PubMedGoogle Scholar
  19. 19.
    Fliser D, Franek E, Joest M, Block S, Mutschler E, Ritz E. Renal function in the elderly: Impact of hypertension and cardiac function. Kidney Int 1997;51(4):1196–204.PubMedCrossRefGoogle Scholar
  20. 20.
    Roderick PJ, Atkins RJ, Smeeth L, et al. Detecting chronic kidney disease in older people; what are the implications? Age Ageing 2008;37(2):179–86.PubMedCrossRefGoogle Scholar
  21. 21.
    Jassal SK, von Muhlen D, Barrett-Connor E. Measures of renal function, BMD, bone loss, and osteoporotic fracture in older adults: The Rancho Bernardo study. J Bone Miner Res 2007;22(2):203–10.PubMedCrossRefGoogle Scholar
  22. 22.
    Artz AS, Fergusson D, Drinka PJ, et al. Mechanisms of unexplained anemia in the nursing home. J Am Geriatr Soc 2004;52(3):423–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Ershler WB, Sheng S, McKelvey J, et al. Serum erythropoietin and aging: A longitudinal analysis. J Am Geriatr Soc 2005;53(8):1360–5.PubMedCrossRefGoogle Scholar
  24. 24.
    Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in persons 65 years and older in the United States: Evidence for a high rate of unexplained anemia. Blood 2004;104(8):2263–8.PubMedCrossRefGoogle Scholar
  25. 25.
    Marx GM, Blake GM, Galani E, et al. Evaluation of the Cockroft-Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients. Ann Oncol 2004;15(2):291–5.PubMedCrossRefGoogle Scholar
  26. 26.
    Coll E, Botey A, Alvarez L, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis 2000;36(1):29–34.PubMedCrossRefGoogle Scholar
  27. 27.
    Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005;352(20):2049–60.PubMedCrossRefGoogle Scholar
  28. 28.
    Lee J, Anggiansah A, Anggiansah R, Young A, Wong T, Fox M. Effects of age on the gastroesophageal junction, esophageal motility, and reflux disease. Clin Gastroenterol Hepatol 2007;5(12):1392–8.PubMedCrossRefGoogle Scholar
  29. 29.
    Drozdowski L, Thomson AB. Aging and the intestine. World J Gastroenterol 2006;12(47):7578–84.PubMedGoogle Scholar
  30. 30.
    Thomson AB, Keelan M. The aging gut. Can J Physiol Pharmacol 1986;64(1):30–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Hopkins MJ, Macfarlane GT. Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection. J Med Microbiol 2002;51(5):448–54.PubMedGoogle Scholar
  32. 32.
    Laugier R, Bernard JP, Berthezene P, Dupuy P. Changes in pancreatic exocrine secretion with age: Pancreatic exocrine secretion does decrease in the elderly. Digestion 1991;50(3–4):202–11.PubMedCrossRefGoogle Scholar
  33. 33.
    Schmucker DL. Liver function and phase I drug metabolism in the elderly: A paradox. Drugs Aging 2001;18(11):837–51.PubMedCrossRefGoogle Scholar
  34. 34.
    Schmucker DL. Age-related changes in liver structure and function: Implications for disease? Exp Gerontol 2005;40(8–9):650–9.PubMedCrossRefGoogle Scholar
  35. 35.
    Schonknecht P, Pantel J, Kruse A, Schroder J. Prevalence and natural course of aging-associated cognitive decline in a population-based sample of young-old subjects. Am J Psychiatry 2005;162(11):2071–7.PubMedCrossRefGoogle Scholar
  36. 36.
    Brennan M, Welsh MC, Fisher CB. Aging and executive function skills: An examination of a community-dwelling older adult population. Percept Mot Skills 1997;84(3 Pt 2):1187–97.PubMedCrossRefGoogle Scholar
  37. 37.
    Busse A, Bischkopf J, Riedel-Heller SG, Angermeyer MC. Mild cognitive impairment: Prevalence and incidence according to different diagnostic criteria. Results of the Leipzig Longitudinal Study of the Aged (LEILA75+). Br J Psychiatry 2003;182:449–54.PubMedCrossRefGoogle Scholar
  38. 38.
    Hanninen T, Koivisto K, Reinikainen KJ, et al. Prevalence of ageing-associated cognitive decline in an elderly population. Age Ageing 1996;25(3):201–5.PubMedCrossRefGoogle Scholar
  39. 39.
    Barker A, Jones R, Jennison C. A prevalence study of age-associated memory impairment. Br J Psychiatry 1995;167(5):642–8.PubMedCrossRefGoogle Scholar
  40. 40.
    Deary IJ, Whiteman MC, Starr JM, Whalley LJ, Fox HC. The impact of childhood intelligence on later life: Following up the Scottish mental surveys of 1932 and 1947. J Pers Soc Psychol 2004;86(1):130–47.PubMedCrossRefGoogle Scholar
  41. 41.
    Evans DA, Beckett LA, Albert MS, et al. Level of education and change in cognitive function in a community population of older persons. Ann Epidemiol 1993;3(1):71–7.PubMedCrossRefGoogle Scholar
  42. 42.
    Rabbitt P, Ibrahim S, Lunn M, et al. Age-associated losses of brain volume predict longitudinal cognitive declines over 8 to 20 years. Neuropsychology 2008;22(1):3–9.PubMedCrossRefGoogle Scholar
  43. 43.
    Charlton RA, Barrick TR, McIntyre DJ, et al. White matter damage on diffusion tensor imaging correlates with age-related cognitive decline. Neurology 2006;66(2):217–22.PubMedCrossRefGoogle Scholar
  44. 44.
    Ritchie K, Artero S, Touchon J. Classification criteria for mild cognitive impairment: A population-based validation study. Neurology 2001;56(1):37–42.PubMedGoogle Scholar
  45. 45.
    Bouxsein ML, Melton LJ, 3rd, Riggs BL, et al. Age- and sex-specific differences in the factor of risk for vertebral fracture: A population-based study using QCT. J Bone Miner Res 2006;21(9):1475–82.PubMedCrossRefGoogle Scholar
  46. 46.
    Perry HM, 3rd, Horowitz M, Morley JE, et al. Aging and bone metabolism in African American and Caucasian women. J Clin Endocrinol Metab 1996;81(3):1108–17.PubMedCrossRefGoogle Scholar
  47. 47.
    Fantin F, Francesco VD, Fontana G, et al. Longitudinal body composition changes in old men and women: Interrelationships with worsening disability. J Gerontol 2007;62(12):1375–81.Google Scholar
  48. 48.
    Newman AB, Lee JS, Visser M, et al. Weight change and the conservation of lean mass in old age: The Health, Aging and Body Composition Study. Am J Clin Nutr 2005;82(4):872–8; quiz 915–6.PubMedGoogle Scholar
  49. 49.
    Zamboni M, Zoico E, Scartezzini T, et al. Body composition changes in stable-weight elderly subjects: The effect of sex. Aging Clin Exp Res 2003;15(4):321–7.PubMedGoogle Scholar
  50. 50.
    Bunout D, de la Maza MP, Barrera G, Leiva L, Gattas V, Hirsch S. Assessment of sarcopenia: Longitudinal versus cross sectional body composition data. Aging Clin Exp Res 2007;19(4):295–9.PubMedGoogle Scholar
  51. 51.
    Gallagher D, Visser M, De Meersman RE, et al. Appendicular skeletal muscle mass: Effects of age, gender, and ethnicity. J Appl Physiol 1997;83(1):229–39.PubMedGoogle Scholar
  52. 52.
    Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998;147(8):755–63.PubMedGoogle Scholar
  53. 53.
    Iannuzzi-Sucich M, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol 2002;57(12):M772–7.Google Scholar
  54. 54.
    Song MY, Ruts E, Kim J, Janumala I, Heymsfield S, Gallagher D. Sarcopenia and increased adipose tissue infiltration of muscle in elderly African American women. Am J Clin Nutr 2004;79(5):874–80.PubMedGoogle Scholar
  55. 55.
    Frontera WR, Hughes VA, Lutz KJ, Evans WJ. A cross-sectional study of muscle strength and mass in 45- to 78-yr-old men and women. J Appl Physiol 1991;71(2):644–50.PubMedGoogle Scholar
  56. 56.
    Estrada M, Kleppinger A, Judge JO, Walsh SJ, Kuchel GA. Functional impact of relative versus absolute sarcopenia in healthy older women. J Am Geriatr Soc 2007;55(11):1712–9.PubMedCrossRefGoogle Scholar
  57. 57.
    Zoico E, Di Francesco V, Guralnik JM, et al. Physical disability and muscular strength in relation to obesity and different body composition indexes in a sample of healthy elderly women. Int J Obes Relat Metab Disord 2004;28(2):234–41.PubMedGoogle Scholar
  58. 58.
    Taaffe DR, Simonsick EM, Visser M, et al. Lower extremity physical performance and hip bone mineral density in elderly black and white men and women: Cross-sectional associations in the Health ABC Study. J Gerontol 2003;58(10):M934–42.Google Scholar
  59. 59.
    Wannamethee SG, Shaper AG, Lennon L, Whincup PH. Decreased muscle mass and increased central adiposity are independently related to mortality in older men. Am J Clin Nutr 2007;86(5):1339–46.PubMedGoogle Scholar
  60. 60.
    Goodpaster BH, Carlson CL, Visser M, et al. Attenuation of skeletal muscle and strength in the elderly: The Health ABC Study. J Appl Physiol 2001;90(6):2157–65.PubMedGoogle Scholar
  61. 61.
    Visser M, Goodpaster BH, Kritchevsky SB, et al. Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons. J Gerontol 2005;60(3):324–33.Google Scholar
  62. 62.
    Ryan AS, Nicklas BJ. Age-related changes in fat deposition in mid-thigh muscle in women: Relationships with metabolic cardiovascular disease risk factors. Int J Obes Relat Metab Disord 1999;23(2):126–32.PubMedCrossRefGoogle Scholar
  63. 63.
    Yim JE, Heshka S, Albu J, et al. Intermuscular adipose tissue rivals visceral adipose tissue in independent associations with cardiovascular risk. Int J Obes 2007;31(9):1400–5.CrossRefGoogle Scholar
  64. 64.
    Martin JA, Buckwalter JA. Aging, articular cartilage chondrocyte senescence and osteoarthritis. Biogerontology 2002;3(5):257–64.PubMedCrossRefGoogle Scholar
  65. 65.
    Sherman BM, West JH, Korenman SG. The menopausal transition: Analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women. J Clin Endocrinol Metab 1976;42(4):629–36.PubMedCrossRefGoogle Scholar
  66. 66.
    Chahal HS, Drake WM. The endocrine system and ageing. J Pathol 2007;211(2):173–80.PubMedCrossRefGoogle Scholar
  67. 67.
    Dallongeville J, Marecaux N, Isorez D, Zylbergberg G, Fruchart JC, Amouyel P. Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in a cohort of French women. Atherosclerosis 1995;118(1):123–33.PubMedCrossRefGoogle Scholar
  68. 68.
    Raisz LG. Pathogenesis of osteoporosis: Concepts, conflicts, and prospects. J Clin Invest 2005;115(12):3318–25.PubMedCrossRefGoogle Scholar
  69. 69.
    Ray P, Ghosh SK, Zhang DH, Ray A. Repression of interleukin-6 gene expression by 17 beta-estradiol: Inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor. FEBS Lett 1997;409(1):79–85.PubMedCrossRefGoogle Scholar
  70. 70.
    Sun WH, Keller ET, Stebler BS, Ershler WB. Estrogen inhibits phorbol ester-induced I kappa B alpha transcription and protein degradation. Biochem Biophys Res Commun 1998;244(3):691–5.PubMedCrossRefGoogle Scholar
  71. 71.
    Morley JE, Kaiser FE, Perry HM, 3rd, et al. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metab Clin Exp 1997;46(4):410–3.PubMedCrossRefGoogle Scholar
  72. 72.
    Gray A, Feldman HA, McKinlay JB, Longcope C. Age, disease, and changing sex hormone levels in middle-aged men: Results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab 1991;73(5):1016–25.PubMedCrossRefGoogle Scholar
  73. 73.
    Meier C, Nguyen TV, Handelsman DJ, et al. Endogenous sex hormones and incident fracture risk in older men: The Dubbo Osteoporosis Epidemiology Study. Arch Intern Med 2008;168(1):47–54.PubMedCrossRefGoogle Scholar
  74. 74.
    Tivesten A, Mellstrom D, Jutberger H, et al. Low serum testosterone and high serum estradiol associate with lower extremity peripheral arterial disease in elderly men. The MrOS Study in Sweden. J Am Coll Cardiol 2007;50(11):1070–6.PubMedCrossRefGoogle Scholar
  75. 75.
    Ferrucci L, Maggio M, Bandinelli S, et al. Low testosterone levels and the risk of anemia in older men and women. Arch Intern Med 2006;166(13):1380–8.PubMedCrossRefGoogle Scholar
  76. 76.
    Khaw KT, Dowsett M, Folkerd E, et al. Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation 2007;116(23):2694–701.PubMedCrossRefGoogle Scholar
  77. 77.
    Keating NL, O'Malley AJ, Smith MR. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol 2006;24(27):4448–56.PubMedCrossRefGoogle Scholar
  78. 78.
    Haren MT, Malmstrom TK, Banks WA, Patrick P, Miller DK, Morley JE. Lower serum DHEAS levels are associated with a higher degree of physical disability and depressive symptoms in middle-aged to older African American women. Maturitas 2007;57(4):347–60.PubMedCrossRefGoogle Scholar
  79. 79.
    Corpas E, Harman SM, Blackman MR. Human growth hormone and human aging. Endocr Rev 1993;14(1):20–39.PubMedGoogle Scholar
  80. 80.
    Aleman A, Verhaar HJ, De Haan EH, et al. Insulin-like growth factor-I and cognitive function in healthy older men. J Clin Endocrinol Metab 1999;84(2):471–5.PubMedCrossRefGoogle Scholar
  81. 81.
    Bergendahl M, Iranmanesh A, Mulligan T, Veldhuis JD. Impact of age on cortisol secretory dynamics basally and as driven by nutrient-withdrawal stress. J Clin Endocrinol Metab 2000;85(6):2203–14.PubMedCrossRefGoogle Scholar
  82. 82.
    Van Cauter E, Leproult R, Kupfer DJ. Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab 1996;81(7):2468–73.PubMedCrossRefGoogle Scholar
  83. 83.
    Purnell JQ, Brandon DD, Isabelle LM, Loriaux DL, Samuels MH. Association of 24-hour cortisol production rates, cortisol-binding globulin, and plasma-free cortisol levels with body composition, leptin levels, and aging in adult men and women. J Clin Endocrinol Metab 2004;89(1):281–7.PubMedCrossRefGoogle Scholar
  84. 84.
    Seeman TE, McEwen BS, Singer BH, Albert MS, Rowe JW. Increase in urinary cortisol excretion and memory declines: MacArthur studies of successful aging. J Clin Endocrinol Metab 1997;82(8):2458–65.PubMedCrossRefGoogle Scholar
  85. 85.
    Seeman TE, Robbins RJ. Aging and hypothalamic-pituitary-adrenal response to challenge in humans. Endocr Rev 1994;15(2):233–60.PubMedGoogle Scholar
  86. 86.
    Meneilly GS, Dawson K, Tessier D. Alterations in glucose metabolism in the elderly patient with diabetes. Diab Care 1993;16(9):1241–8.CrossRefGoogle Scholar
  87. 87.
    Meneilly GS, Elahi D, Minaker KL, Sclater AL, Rowe JW. Impairment of noninsulin-mediated glucose disposal in the elderly. J Clin Endocrinol Metab 1989;68(3):566–71.PubMedCrossRefGoogle Scholar
  88. 88.
    Meneilly GS, Ryan AS, Minaker KL, Elahi D. The effect of age and glycemic level on the response of the beta-cell to glucose-dependent insulinotropic polypeptide and peripheral tissue sensitivity to endogenously released insulin. J Clin Endocrinol Metab 1998;83(8):2925–32.PubMedCrossRefGoogle Scholar
  89. 89.
    Fink RI, Kolterman OG, Griffin J, Olefsky JM. Mechanisms of insulin resistance in aging. J Clin Invest 1983;71(6):1523–35.PubMedCrossRefGoogle Scholar
  90. 90.
    Gruver AL, Hudson LL, Sempowski GD. Immunosenescence of ageing. J Pathol 2007;211(2):144–56.PubMedCrossRefGoogle Scholar
  91. 91.
    Tsuboi I, Morimoto K, Horie T, Mori KJ. Age-related changes in various hemopoietic progenitor cells in senescence-accelerated (SAM-P) mice. Exp Hematol 1991;19(9):874–7.PubMedGoogle Scholar
  92. 92.
    Izumi-Hisha H, Ito Y, Sugimoto K, Oshima H, Mori KJ. Age-related decrease in the number of hemopoietic stem cells and progenitors in senescence accelerated mice. Mech Ageing Dev 1990;56(1):89–97.PubMedCrossRefGoogle Scholar
  93. 93.
    Sakuma A, Tsuboi I, Morimoto K, Horie T, Sugimoto K, Mori KJ. Age-related decreases in the reconstituting ability of hemopoietic cells and the ability of hemopoietic microenvironment to support hemopoietic reconstitution in senescence accelerated (SAM-P) mice. Mech Ageing Dev 1994;73(2):127–35.PubMedCrossRefGoogle Scholar
  94. 94.
    Miller RA. The aging immune system: Primer and prospectus. Science 1996;273(5271):70–4.PubMedCrossRefGoogle Scholar
  95. 95.
    Miller JP, Allman D. The decline in B lymphopoiesis in aged mice reflects loss of very early B-lineage precursors. J Immunol 2003;171(5):2326–30.PubMedGoogle Scholar
  96. 96.
    Colonna-Romano G, Aquino A, Bulati M, et al. Memory B cell subpopulations in the aged. Rejuv Res 2006;9(1):149–52.CrossRefGoogle Scholar
  97. 97.
    Sansoni P, Vescovini R, Fagnoni F, et al. The immune system in extreme longevity. Exp Gerontol 2008;43(2):61–5.PubMedCrossRefGoogle Scholar
  98. 98.
    Powers DC. Influenza A virus-specific cytotoxic T lymphocyte activity declines with advancing age. J Am Geriatr Soc 1993;41(1):1–5.PubMedGoogle Scholar
  99. 99.
    Ershler WB, Keller ET. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 2000;51:245–70.PubMedCrossRefGoogle Scholar
  100. 100.
    Mascarucci P, Taub D, Saccani S, et al. Age-related changes in cytokine production by leukocytes in rhesus monkeys. Aging (Milan, Italy) 2001;13(2):85–94.Google Scholar
  101. 101.
    Mascarucci P, Taub D, Saccani S, et al. Cytokine responses in young and old rhesus monkeys: Effect of caloric restriction. J Interferon Cytokine Res 2002;22(5):565–71.PubMedCrossRefGoogle Scholar
  102. 102.
    Daynes RA, Araneo BA, Ershler WB, Maloney C, Li GZ, Ryu SY. Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. J Immunol 1993;150(12):5219–30.PubMedGoogle Scholar
  103. 103.
    Kania DM, Binkley N, Checovich M, Havighurst T, Schilling M, Ershler WB. Elevated plasma levels of interleukin-6 in postmenopausal women do not correlate with bone density. J Am Geriatr Soc 1995;43(3):236–9.PubMedGoogle Scholar
  104. 104.
    Fagiolo U, Cossarizza A, Scala E, et al. Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol 1993;23(9):2375–8.PubMedCrossRefGoogle Scholar
  105. 105.
    Young DG, Skibinski G, Mason JI, James K. The influence of age and gender on serum dehydroepiandrosterone sulphate (DHEA-S), IL-6, IL-6 soluble receptor (IL-6 sR) and transforming growth factor beta 1 (TGF-beta1) levels in normal healthy blood donors. Clin Exp Immunol 1999;117(3):476–81.PubMedCrossRefGoogle Scholar
  106. 106.
    Straub RH, Konecna L, Hrach S, et al. Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: Possible link between endocrinosenescence and immunosenescence. J Clin Endocrinol Metab 1998;83(6):2012–7.PubMedCrossRefGoogle Scholar
  107. 107.
    Chorinchath BB, Kong LY, Mao L, McCallum RE. Age-associated differences in TNF-alpha and nitric oxide production in endotoxic mice. J Immunol 1996;156(4):1525–30.PubMedGoogle Scholar
  108. 108.
    O'Mahony L, Holland J, Jackson J, Feighery C, Hennessy TP, Mealy K. Quantitative intracellular cytokine measurement: Age-related changes in proinflammatory cytokine production. Clin Exp Immunol 1998;113(2):213–9.PubMedCrossRefGoogle Scholar
  109. 109.
    Roubenoff R, Harris TB, Abad LW, Wilson PW, Dallal GE, Dinarello CA. Monocyte cytokine production in an elderly population: Effect of age and inflammation. J Gerontol 1998;53(1):M20–6.Google Scholar
  110. 110.
    Wu D, Ren Z, Pae M, et al. Aging up-regulates expression of inflammatory mediators in mouse adipose tissue. J Immunol 2007;179(7):4829–39.PubMedGoogle Scholar
  111. 111.
    Tracy RP, Arnold AM, Ettinger W, Fried L, Meilahn E, Savage P. The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: Results from the cardiovascular health study. Arterioscler Thromb Vasc Biol 1999;19(7):1776–83.PubMedCrossRefGoogle Scholar
  112. 112.
    Yamamoto K, Takeshita K, Shimokawa T, et al. Plasminogen activator inhibitor-1 is a major stress-regulated gene: Implications for stress-induced thrombosis in aged individuals. Proc Natl Acad Sci U S A 2002;99(2):890–5.PubMedCrossRefGoogle Scholar
  113. 113.
    Laharrague PF, Cambus JP, Fillola G, Corberand JX. Plasma fibrinogen and physiological aging. Aging (Milan, Italy) 1993;5(6):445–9.Google Scholar
  114. 114.
    Pieper CF, Rao KM, Currie MS, Harris TB, Chen HJ. Age, functional status, and racial differences in plasma D-dimer levels in community-dwelling elderly persons. J Gerontol 2000;55(11):M649–57.Google Scholar
  115. 115.
    Cohen HJ, Harris T, Pieper CF. Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am J Med 2003;114(3):180–7.PubMedCrossRefGoogle Scholar
  116. 116.
    Tracy RP, Bovill EG, Yanez D, et al. Fibrinogen and factor VIII, but not factor VII, are associated with measures of subclinical cardiovascular disease in the elderly. Results from The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1995;15(9):1269–79.PubMedCrossRefGoogle Scholar
  117. 117.
    Taaffe DR, Harris TB, Ferrucci L, Rowe J, Seeman TE. Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. J Gerontol 2000;55(12):M709–15.Google Scholar
  118. 118.
    Harris TB, Ferrucci L, Tracy RP, et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999;106(5):506–12.PubMedCrossRefGoogle Scholar
  119. 119.
    Yaffe K, Lindquist K, Penninx BW, et al. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 2003;61(1):76–80.PubMedGoogle Scholar
  120. 120.
    Abbatecola AM, Ferrucci L, Grella R, et al. Diverse effect of inflammatory markers on insulin resistance and insulin-resistance syndrome in the elderly. J Am Geriatr Soc 2004;52(3):399–404.PubMedCrossRefGoogle Scholar
  121. 121.
    Cesari M, Leeuwenburgh C, Lauretani F, et al. Frailty syndrome and skeletal muscle: Results from the Invecchiare in Chianti study. Am J Clin Nutr 2006;83(5):1142–8.PubMedGoogle Scholar
  122. 122.
    Pai JK, Pischon T, Ma J, et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 2004;351(25):2599–610.PubMedCrossRefGoogle Scholar
  123. 123.
    Shlipak MG, Fried LF, Crump C, et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 2003;107(1):87–92.PubMedCrossRefGoogle Scholar
  124. 124.
    Ding C, Parameswaran V, Udayan R, Burgess J, Jones G. Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: A longitudinal study. J Clin Endocrinol Metab 2008;93(5):1952–8.PubMedCrossRefGoogle Scholar
  125. 125.
    Spranger J, Kroke A, Mohlig M, et al. Inflammatory cytokines and the risk to develop type 2 diabetes: Results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 2003;52(3):812–7.PubMedCrossRefGoogle Scholar
  126. 126.
    Ferrucci L, Guralnik JM, Woodman RC, et al. Proinflammatory state and circulating erythropoietin in persons with and without anemia. Am J Med 2005;118(11):1288.PubMedCrossRefGoogle Scholar
  127. 127.
    Wilson CJ, Cohen HJ, Pieper CF. Cross-linked fibrin degradation products (D-dimer), plasma cytokines, and cognitive decline in community-dwelling elderly persons. J Am Geriatr Soc 2003;51(10):1374–81.PubMedCrossRefGoogle Scholar
  128. 128.
    Walston J, Hadley EC, Ferrucci L, et al. Research agenda for frailty in older adults: Toward a better understanding of physiology and etiology: Summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc 2006;54(6):991–1001.PubMedCrossRefGoogle Scholar
  129. 129.
    Walston J, McBurnie MA, Newman A, et al. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: Results from the Cardiovascular Health Study. Arch Intern Med 2002;162(20):2333–41.PubMedCrossRefGoogle Scholar
  130. 130.
    Woods NF, LaCroix AZ, Gray SL, et al. Frailty: Emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study. J Am Geriatr Soc 2005;53(8):1321–30.PubMedCrossRefGoogle Scholar
  131. 131.
    Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: Evidence for a phenotype. J Gerontol 2001;56(3):M146–56.Google Scholar
  132. 132.
    Rockwood K, Howlett SE, MacKnight C, et al. Prevalence, attributes, and outcomes of fitness and frailty in community-dwelling older adults: Report from the Canadian study of health and aging. J Gerontol 2004;59(12):1310–7.Google Scholar
  133. 133.
    Newman AB, Gottdiener JS, McBurnie MA, et al. Associations of subclinical cardiovascular disease with frailty. J Gerontol 2001;56(3):M158–66.Google Scholar
  134. 134.
    Barzilay JI, Blaum C, Moore T, et al. Insulin resistance and inflammation as precursors of frailty: The Cardiovascular Health Study. Arch Intern Med 2007;167(7):635–41.PubMedCrossRefGoogle Scholar
  135. 135.
    Artz AS, Fergusson D, Drinka PJ, et al. Prevalence of anemia in skilled-nursing home residents. Arch Gerontol Geriatr 2004;39(3):201–6.PubMedCrossRefGoogle Scholar
  136. 136.
    Wood LJ, Nail LM, Gilster A, Winters KA, Elsea CR. Cancer chemotherapy-related symptoms: Evidence to suggest a role for proinflammatory cytokines. Oncol Nurs Forum 2006;33(3):535–42.PubMedCrossRefGoogle Scholar
  137. 137.
    Blackwell K, Haroon Z, Broadwater G, et al. Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status. J Clin Oncol 2000;18(3):600–8.PubMedGoogle Scholar
  138. 138.
    Blackwell K, Hurwitz H, Lieberman G, et al. Circulating D-dimer levels are better predictors of overall survival and disease progression than carcinoembryonic antigen levels in patients with metastatic colorectal carcinoma. Cancer 2004;101(1):77–82.PubMedCrossRefGoogle Scholar
  139. 139.
    Lauta VM. A review of the cytokine network in multiple myeloma: Diagnostic, prognostic, and therapeutic implications. Cancer 2003;97(10):2440–52.PubMedCrossRefGoogle Scholar
  140. 140.
    Songur N, Kuru B, Kalkan F, Ozdilekcan C, Cakmak H, Hizel N. Serum interleukin-6 levels correlate with malnutrition and survival in patients with advanced non-small cell lung cancer. Tumori 2004;90(2):196–200.PubMedGoogle Scholar
  141. 141.
    Drachenberg DE, Elgamal AA, Rowbotham R, Peterson M, Murphy GP. Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer. Prostate 1999;41(2):127–33.PubMedCrossRefGoogle Scholar
  142. 142.
    Ramsey S, Lamb GW, Aitchison M, Graham J, McMillan DC. Evaluation of an inflammation-based prognostic score in patients with metastatic renal cancer. Cancer 2007;109(2):205–12.PubMedCrossRefGoogle Scholar
  143. 143.
    Lamb GW, McArdle PA, Ramsey S, et al. The relationship between the local and systemic inflammatory responses and survival in patients undergoing resection for localized renal cancer. BJU Int 2008;102(6):756–61.PubMedCrossRefGoogle Scholar
  144. 144.
    Kanapuru B, Posani K, Muller D, Ershler WB. Decreased cancer prevalence in the nursing home. J Am Geriatr Soc 2008; 56(11):2165–6.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.National Institute of HealthBaltimoreUSA

Personalised recommendations